SEC Form 4 · accession 0001645627-17-000032
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 10, 2017
Accepted (ET)
Apr 13, 2017 · 8:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 10, 2017 | P | 1,000 | $0.085 | A | 20,092,849 | D | |
| Common Stock | Apr 10, 2017 | P | 1,000 | $0.085 | A | 20,093,849 | D | |
| Common Stock | Apr 10, 2017 | P | 1,000 | $0.085 | A | 20,094,849 | D | |
| Common Stock | Apr 10, 2017 | P | 1,000 | $0.084 | A | 20,095,849 | D | |
| Common Stock | Apr 10, 2017 | P | 1,000 | $0.084 | A | 20,096,849 | D | |
| Common Stock | Apr 10, 2017 | P | 1,000 | $0.0819 | A | 20,097,849 | D | |
| Common Stock | Apr 10, 2017 | P | 1,000 | $0.0805 | A | 20,098,849 | D | |
| Common Stock | Apr 10, 2017 | P | 1,000 | $0.0805 | A | 20,099,849 | D | |
| Common Stock | Apr 10, 2017 | P | 1,000 | $0.085 | A | 20,100,849 | D | |
| Common Stock | Apr 10, 2017 | P | 1,000 | $0.0805 | A | 20,101,849 | D | |
| Common Stock | Apr 10, 2017 | P | 1,000 | $0.0805 | A | 20,102,849 | D | |
| Common Stock | Apr 10, 2017 | P | 275 | $0.0805 | A | 20,103,124 | D | |
| Common Stock | Apr 10, 2017 | P | 725 | $0.0806 | A | 20,103,849 | D | |
| Common Stock | Apr 10, 2017 | P | 1,000 | $0.0799 | A | 20,104,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0799 | A | 20,105,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0799 | A | 20,106,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0789 | A | 20,107,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.078 | A | 20,108,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0765 | A | 20,109,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0764 | A | 20,110,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0765 | A | 20,111,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0765 | A | 20,112,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0765 | A | 20,113,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0765 | A | 20,114,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0765 | A | 20,115,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0765 | A | 20,116,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0713 | A | 20,117,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0765 | A | 20,118,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0738 | A | 20,119,849 | D | |
| Common Stock | Apr 11, 2017 | P | 1,000 | $0.0736 | A | 20,120,849 | D |
Table II — derivative securities
No Table II lines on this filing.